Edgewood Management LLC Seres Therapeutics, Inc. Transaction History

Edgewood Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$4.67 - $6.55 $233,500 - $327,500	-50,000 Reduced 50.0%	50,000 $239,000
Q3 2022 Nov 10, 2022	BUY	$3.5 - $7.2 $350,000 - $720,000	100,000 New	100,000 $642,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.62 $189,000 - $533,400	-70,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.02 - $11.43 $60,199 - $114,300	10,000 Added 16.67%	70,000 $583,000
Q3 2021 Nov 12, 2021	BUY	$5.46 - $22.6 $109,200 - $452,000	20,000 Added 50.0%	60,000 $418,000
Q2 2021 Aug 12, 2021	BUY	$18.46 - $24.36 $276,900 - $365,400	15,000 Added 60.0%	40,000 $954,000
Q1 2021 May 13, 2021	BUY	$17.66 - $28.92 $441,500 - $723,000	25,000 New	25,000 $515,000

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $95.5M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Edgewood Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edgewood Management LLC with notifications on news.